139 related articles for article (PubMed ID: 31481134)
1. Outcomes of extended-spectrum beta-lactamases producing Enterobacteriaceae colonization among patients abdominal surgery patients.
Apisarnthanarak A; Kondo S; Mingmalairak C; Mahawongkajit P; Juntong J; Limpavitayaporn P; Sriussadaporn E; Tongyoo A; Mundy LM
Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1290-1293. PubMed ID: 31481134
[TBL] [Abstract][Full Text] [Related]
2. Surgical site infection with extended-spectrum β-lactamase-producing Enterobacteriaceae after cardiac surgery: incidence and risk factors.
Jolivet S; Lescure FX; Armand-Lefevre L; Raffoul R; Dilly MP; Ghodbane W; Nataf P; Lucet JC
Clin Microbiol Infect; 2018 Mar; 24(3):283-288. PubMed ID: 28698036
[TBL] [Abstract][Full Text] [Related]
3. Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the Risk of Surgical Site Infection After Colorectal Surgery: A Prospective Cohort Study.
Dubinsky-Pertzov B; Temkin E; Harbarth S; Fankhauser-Rodriguez C; Carevic B; Radovanovic I; Ris F; Kariv Y; Buchs NC; Schiffer E; Cohen Percia S; Nutman A; Fallach N; Klausner J; Carmeli Y;
Clin Infect Dis; 2019 May; 68(10):1699-1704. PubMed ID: 30204851
[TBL] [Abstract][Full Text] [Related]
4. High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.
Moremi N; Claus H; Rutta L; Frosch M; Vogel U; Mshana SE
J Hosp Infect; 2018 Sep; 100(1):47-53. PubMed ID: 29852267
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem for Surgical Site Infection Prophylaxis in Prevalent Regions of Extended-Spectrum β-Lactamase Enterobacteriaceae.
Apisarnthanarak A; Apisarnthanarak P
Clin Infect Dis; 2020 Nov; 71(8):2024-2025. PubMed ID: 32633318
[No Abstract] [Full Text] [Related]
6. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
7. Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Prinapori R; Guinaud J; Khalil A; Lecuyer H; Gendrel D; Lortholary O; Nassif X; Viscoli C; Zahar JR
Am J Infect Control; 2013 Mar; 41(3):259-60. PubMed ID: 23062579
[TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Pilmis B; Delory T; Groh M; Weiss E; Emirian A; Lecuyer H; Lesprit P; Zahar JR
Int J Infect Dis; 2015 Oct; 39():62-7. PubMed ID: 26327124
[TBL] [Abstract][Full Text] [Related]
9. Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) colonization as a risk factor for developing ESBL infections in pediatric cardiac surgery patients: "retrospective cohort study".
Cheikh A; Belefquih B; Chajai Y; Cheikhaoui Y; El Hassani A; Benouda A
BMC Infect Dis; 2017 Mar; 17(1):237. PubMed ID: 28356079
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae.
Nakai H; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Yamagishi Y; Mikamo H
J Infect Chemother; 2016 May; 22(5):319-26. PubMed ID: 26968486
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
Vodovar D; Marcadé G; Rousseau H; Raskine L; Vicaut E; Deye N; Baud FJ; Mégarbane B
Infection; 2014 Aug; 42(4):743-8. PubMed ID: 24728816
[TBL] [Abstract][Full Text] [Related]
12. Non-intravenous carbapenem-sparing antibiotics for definitive treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase: A propensity score study.
Meije Y; Pigrau C; Fernández-Hidalgo N; Clemente M; Ortega L; Sanz X; Loureiro-Amigo J; Sierra M; Ayestarán A; Morales-Cartagena A; Ribera A; Duarte A; Abelenda G; Rodríguez-Baño J; Martínez-Montauti J
Int J Antimicrob Agents; 2019 Aug; 54(2):189-196. PubMed ID: 31075401
[TBL] [Abstract][Full Text] [Related]
13. Colonization by fecal extended-spectrum β-lactamase-producing Enterobacteriaceae and surgical site infections in patients with cancer undergoing gastrointestinal and gynecologic surgery.
Golzarri MF; Silva-Sánchez J; Cornejo-Juárez P; Barrios-Camacho H; Chora-Hernández LD; Velázquez-Acosta C; Vilar-Compte D
Am J Infect Control; 2019 Aug; 47(8):916-921. PubMed ID: 30850249
[TBL] [Abstract][Full Text] [Related]
14. ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
Detsis M; Karanika S; Mylonakis E
Crit Care Med; 2017 Apr; 45(4):705-714. PubMed ID: 28157141
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
Bindayna KM; Senok AC; Jamsheer AE
J Infect Public Health; 2009; 2(3):129-35. PubMed ID: 20701872
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
Sfeir MM; Askin G; Christos P
Int J Antimicrob Agents; 2018 Nov; 52(5):554-570. PubMed ID: 30081138
[TBL] [Abstract][Full Text] [Related]
18. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
[TBL] [Abstract][Full Text] [Related]
19. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
[TBL] [Abstract][Full Text] [Related]
20. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
Birgand G; Armand-Lefevre L; Lolom I; Ruppe E; Andremont A; Lucet JC
Am J Infect Control; 2013 May; 41(5):443-7. PubMed ID: 22998785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
